Hopkinson Craig C. Insider Trades

Insider Trading History

Track insider trading activity for Hopkinson Craig C.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Alkermes plc
Alkermes plc ALKS
EVP R&d, Chief Medical Officer
Holding Value $70k 1,356 shares
Last Trade
Jul 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$259k 5,000 shares
$51.72
$51.60
Alkermes plc
Alkermes plc ALKS
EVP R&d, Chief Medical Officer
Holding Value $3.82M 74,089 shares
Last Trade
Jul 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$464k 9,000 shares
$51.51
$51.60
Alkermes plc
Alkermes plc ALKS
EVP R&d, Chief Medical Officer
Holding Value $4.25M 82,389 shares
Last Trade
Jul 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$259k 5,000 shares
$51.72
$51.60
Alkermes plc
Alkermes plc ALKS
EVP R&d, Chief Medical Officer
Holding Value $328k 6,356 shares
Last Trade
Jun 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$211k 5,000 shares
$42.27
$51.60
Alkermes plc
Alkermes plc ALKS
EVP R&d, Chief Medical Officer
Holding Value $4.46M 86,389 shares
Last Trade
Jun 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$211k 5,000 shares
$42.27
$51.60
Alkermes plc
Alkermes plc ALKS
EVP R&d, Chief Medical Officer
Holding Value $3.99M 77,389 shares
Last Trade
Jun 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$375k 9,000 shares
$41.67
$51.60
Alkermes plc
Alkermes plc ALKS
EVP R&d, Chief Medical Officer
Holding Value $586k 11,356 shares
Last Trade
May 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$167k 5,000 shares
$33.38
$51.60
Alkermes plc
Alkermes plc ALKS
EVP R&d, Chief Medical Officer
Holding Value $4.66M 90,389 shares
Last Trade
May 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$167k 5,000 shares
$33.38
$51.60
Alkermes plc
Alkermes plc ALKS
EVP R&d, Chief Medical Officer
Holding Value $4.2M 81,389 shares
Last Trade
May 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$301k 9,000 shares
$33.40
$51.60
Alkermes plc
Alkermes plc ALKS
EVP R&d, Chief Medical Officer
Holding Value $844k 16,356 shares
Last Trade
Apr 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$175k 5,000 shares
$35.05
$51.60
Alkermes plc
Alkermes plc ALKS
EVP R&d, Chief Medical Officer
Holding Value $4.87M 94,389 shares
Last Trade
Apr 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$175k 5,000 shares
$35.05
$51.60
Alkermes plc
Alkermes plc ALKS
EVP R&d, Chief Medical Officer
Holding Value $4.41M 85,389 shares
Last Trade
Apr 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$320k 9,000 shares
$35.51
$51.60
Alkermes plc
Alkermes plc ALKS
EVP R&d, Chief Medical Officer
Holding Value $1.1M 21,356 shares
Last Trade
Mar 02, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$151k 5,000 shares
$30.25
$51.60
Alkermes plc
Alkermes plc ALKS
EVP R&d, Chief Medical Officer
Holding Value $4.28M 83,037 shares
Last Trade
Mar 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.68M 121,605 shares
$30.25
$51.60
Alkermes plc
Alkermes plc ALKS
EVP R&d, Chief Medical Officer
Holding Value $4.61M 89,389 shares
Last Trade
Mar 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$267k 9,000 shares
$29.72
$51.60
Alkermes plc
Alkermes plc ALKS
EVP R&d, Chief Medical Officer
Holding Value $5.08M 98,389 shares
Last Trade
Mar 02, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$151k 5,000 shares
$30.25
$51.60
Alkermes plc
Alkermes plc ALKS
EVP R&d, Chief Medical Officer
Holding Value $709k 13,732 shares
Last Trade
Feb 26, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$211k 6,866 shares
$30.73
$51.60
Alkermes plc
Alkermes plc ALKS
EVP R&d, Chief Medical Officer
Holding Value $4.82M 93,389 shares
Last Trade
Feb 26, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$93.7k 3,049 shares
$30.73
$51.60
Alkermes plc
Alkermes plc ALKS
EVP R&d, Chief Medical Officer
Holding Value $4.98M 96,438 shares
Last Trade
Feb 26, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$211k 6,866 shares
$30.73
$51.60
Alkermes plc
Alkermes plc ALKS
EVP R&d, Chief Medical Officer
Holding Value $4.62M 89,572 shares
Last Trade
Feb 23, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$110k 3,414 shares
$32.19
$51.60

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up